Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Current Topics in Medicinal Chemistry
|
February 20, 2010
Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands
Simon E Ward, Jeannette M Watson
CNS Neuroscience & Therapeutics
|
June 9, 2009
Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders
Lee A Dawson, Jeannette M Watson
CNS Drug Reviews
|
July 14, 2007
Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy
Jeannette M Watson, Lee A Dawson
Current Opinion in Pharmacology
|
January 12, 2002
Serotonergic targets in depression
Derek N Middlemiss, Gary W Price, Jeannette M Watson
Expert Opinion on Investigational Drugs
|
April 2, 2002
Therapeutic potential of serotonin antagonists in depressive disorders
Martyn D Wood, David R Thomas, Jeannette M Watson
Molecular Pharmacology
|
September 10, 2009
Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor
Sophie J Bradley, Jeannette M Watson, R A John Challiss
Molecular Pharmacology
|
February 16, 2011
Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia
Sophie J Bradley, Christopher J Langmead, Jeannette M Watson, et al.
BMC Neuroscience
|
May 1, 2012
Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex
Sylvain Gigout, Gareth A Jones, Stephan Wierschke, et al.
European Journal of Pharmacology
|
December 1, 2010
The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding
Kathryn L Chapman, Dina Vaswani, Nicola Hendry, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist
Simon E Ward, Frank P Harrington, Laurie J Gordon, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Current Topics in Medicinal Chemistry
|
February 20, 2010
Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands
Simon E Ward, Jeannette M Watson
CNS Neuroscience & Therapeutics
|
June 9, 2009
Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders
Lee A Dawson, Jeannette M Watson
CNS Drug Reviews
|
July 14, 2007
Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy
Jeannette M Watson, Lee A Dawson
Current Opinion in Pharmacology
|
January 12, 2002
Serotonergic targets in depression
Derek N Middlemiss, Gary W Price, Jeannette M Watson
Expert Opinion on Investigational Drugs
|
April 2, 2002
Therapeutic potential of serotonin antagonists in depressive disorders
Martyn D Wood, David R Thomas, Jeannette M Watson
Molecular Pharmacology
|
September 10, 2009
Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor
Sophie J Bradley, Jeannette M Watson, R A John Challiss
Molecular Pharmacology
|
February 16, 2011
Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia
Sophie J Bradley, Christopher J Langmead, Jeannette M Watson, et al.
BMC Neuroscience
|
May 1, 2012
Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex
Sylvain Gigout, Gareth A Jones, Stephan Wierschke, et al.
European Journal of Pharmacology
|
December 1, 2010
The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding
Kathryn L Chapman, Dina Vaswani, Nicola Hendry, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist
Simon E Ward, Frank P Harrington, Laurie J Gordon, et al.
Page
of 4